Another NIH $23 Million In CORRUPTED RESEARCH

Pharmalittle has:

How Many More Have Been Faked?

"Yet another reason why it is so important to strike down preemption in ANY form ....

Two researchers conducting animal studies on immunosuppression lied about experimental methodologies and falsified data in 16 papers and several grants produced over the past 8 years, according to the Office of Research Integrity (ORI).

The scientists, Judith Thomas and Juan Contreras, formerly at the University of Alabama at Birmingham (UAB), falsely reported that they performed double kidney removals on several rhesus macaques in experiments designed to test the effectiveness of two immune suppressing drugs -- Immunotoxin FN18-CRM9 and 15-deoxyspergualin (15-DSG) -- in preventing rejection of the a single transplanted kidney."

At Pharmalittle you can click through Their link to read the entire article, ..... and see what kind of Corrupted Research Integrity you got in trade for $23 Million NIH Dollars, ..... which the Fed Reserve Printed: clipping you at Least Four or Five times:

1st: by Buying this Corrupt Research without properly Overseeing it

2nd: by sucking the Equity out of what You saved through inflating the Money Supply

3rd: by allowing the unintentional Biasing/Corruption/Waste of Subsequent Research (and possible harm to patients) based upon the Initially Corrupt Research, ...... and on infinitum

4&5: see #3

These Kidney Transplant Monkey Shines went on for 8 Years, and our $28 Billion Dollar NIH couldn't afford to catch them.

Transferring even $2 Billion out of NIH to DOJ to hire more Investigators & Prosecutors assigned exclusively to the Pharma/Health/Academic Medicine sectors would make considerably more sense in assuring that what NIH Does fund with their remaining $26 Billion doesn't have to be Scrapped and Re-Researched, or investigated by the Senate Finance Committee.

Kaisernetwork.org from last July has:

More Than 500 Backlogged Whistle-Blower Cases Allege Health Care, Drug Company Fraud

"Whistle-blower lawsuits alleging that pharmaceutical companies and government contractors defrauded the federal government have created a backlog of more than 900 cases at the Department of Justice, the Washington Post reports. According to the Post, more than 500 of the cases involve the health care and pharmaceutical industries, as well as Medicare and Medicaid.

Patrick Burns, a spokesperson for Taxpayers Against Fraud, said, "Even if no new cases are filed, it might take 10 years for the Department of Justice to clear its desk.

Lawyers involved in the backlogged disputes say DOJ "cannot keep pace with the surge in charges brought by whistle-blowers," the Post reports. Since 2001, 300 to 400 civil cases have been filed each year; however, the 75-lawyer unit that reviews the allegations investigates about 100 cases annually. Whistle-blowers routinely wait 14 or more months to find out whether DOJ will get involved in the case, during which time whistle-blowers are not allowed to discuss or disclose the existence of such disputes. The government rejects about three-quarters of the cases it receives, saying the majority lack merit.